It is well described in the literature that epithelial damage resulting from allergic inflammation results in epithelial mediator production, such as TGF-β (Davies, 2009), which mediates smooth muscle hypertrophy in asthma and promotes faster and more sustained contraction (Boxall et al., 2006). This evidence concerns the gene TGFB1 and asthma.